MDT Stock Analysis: Medtronic Plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitorin
- Latest close
- $86.29
- 20-day change
- -6.25%
- Trend state
- NEUTRAL
- Classification
- Healthcare · Medical - Devices
Market context
Medtronic Plc moved -6.25% over the latest 20-session window. BullRecon currently classifies the broader setup as NEUTRAL.
Latest report
The latest cached company filing period (FY2026 · $36.4B revenue · $4.8B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Quality is currently the strongest dimension at 5.3/6, while Growth is the lowest at 3.8/6. Scores are comparative research signals, not forecasts.